Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ECLIPSE METALS LIMITED. Share Issue/Capital Change 2015

Dec 22, 2015

64863_rns_2015-12-22_8e87be22-a22c-41a3-921c-5d890a0c4f21.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity Eclipse Metals Limited
ACN 142 366 541

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of +securities issued or to be issued
2
Number of +securities issued or to be
issued (if known) or maximum number which
may be issued
3
Principal terms of the+securities (eg, if
options, exercise price and expiry date; if
partly
paid
+securities,
the
amount
outstanding and due dates for payment; if
+convertible securities, the conversion price
and dates for conversion)
4
Do the+securities rank equally in all
respects from the date of allotment with an
existing+class of quoted+securities?
If the additional securities do not rank
equally, please state:

the date from which they do

the extent to which they participate for
the next dividend, (in the case of a trust,
distribution) or interest payment

the extent to which they do not rank
equally, other than in relation to the next
dividend, distribution or interest payment
5
Issue price or consideration
Shares
17,000,000
Fully Paid Ordinary Shares rank equally
Shares issued will rank equally with existing fully
paid Ordinary Shares on issue
14,000,000 Shares
Deemed issue price of $0.005 per Share being
the closing Share price as at 21 December 2015.
3,000,000 Shares
Deemed issue price of $0.005 per Share being
the closing Share price as at 22 June 2015, being
the date ofShare SaleAgreement.
  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 1

6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly identify
those assets)
6a
Is the entity an+eligible entity that has
obtained security holder approval under rule
7.1A?
If Yes, complete sections 6b – 6h_in relation_
to the+securities the subject of this
Appendix 3B, and comply with section 6i
6b
The date the security holder resolution under
rule 7.1A was passed
6c
Number
of
+securities
issued
without
security holder approval under rule 7.1
6d
Number of+securities issued with security
holder approval under rule 7.1A
6e
Number of+securities issued with security
holder approval under rule 7.3, or another
specific security holder approval (specify
date of meeting)
6f
Number of securities issued under an
exception in rule 7.2
6g
If securities issued under rule 7.1A, was
issue price at least 75% of 15 day VWAP as
calculated under rule 7.1A.3? Include the
issue date and both values. Include the
source of the VWAP calculation.
6h
If securities were issued under rule 7.1A for
non-cash consideration, state date on which
valuation of consideration was released to
ASX Market Announcements
14,000,000 Shares
Issue of fully paid Ordinary Shares to the Director
in lieu of fees in accordance:

With
Item
9
Section
611
of
the
Corporations
Act
2001
(11,000,000
Shares); and

Six (6) months outstanding director fees
for 1 April to 30 June 2015 and 1
September
to
30
November
2015
(3,000,000 Shares)
3,000,000 Shares
Acquisition of 11,250,000 Shares in Walla Mines
Proprietary
Limited,
a
subsidiary
that
the
Company currently has a controlling interest of
55.81% in.
The
acquisition
of
the
Shares
was
from
Bluekebble Pty Ltd, a related party of the
Company by virtue of being controlled by the
spouse of the former Executive Director.
These
Share
issues
were
approved
by
Shareholders at the 2015 Annual General
Meeting.
Yes
At the Company’s Annual General Meeting held
on30November 2015
Nil
Nil
17,000,000 Shares
(Approved at the 30 November 2015 Annual
General Meeting)
Nil
N/A
N/A
  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 2

6i Calculate the entity’s remaining issue Remaining Issue Capacity under Rule 7.1 capacity under rule 7.1 and rule 7.1A – 124,495,043 Securities complete Annexure 1 and release to ASX Market Announcements Remaining Issue Capacity under Rule 7.1A 82,996,695 Shares 7 Dates of entering +securities into 22 December 2015 uncertificated holdings or despatch of certificates Number Class 8 Current Number and[+] class of all[+] securities 829,966,947 Ordinary Shares quoted on ASX Number Class 9 Number and +class of all +securities not 103,023,813 30 November 2016 quoted on ASX (including the securities in Unlisted Options at 6 clause 2 if applicable) cents

  • 10 Dividend policy (in the case of a trust, Not Applicable distribution policy) on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue

Questions 11 to 33 are not applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities ( tick one )

  • (a)

  • Securities described in Part 1

  • (b) All other securities

Example: Restricted securities at the end of the escrowed period, Partly paid securities that become fully paid, Employee incentive share securities when restriction ends and Securities issued on expiry or conversion of convertible securities

Questions 35 to 42 not applicable

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 3

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

==> picture [153 x 71] intentionally omitted <==

Date: 22 December 2015

Print name: Eryn Kestel Company Secretary

  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 4

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 1 Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insertnumber of fully paid ordinary
securities on issue 12 months before date
of issue or agreement to issue
596,106,824
Addthe following:
• Number of fully paid ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid ordinary securities
that became fully paid in that 12 month
period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
165,860,123
38,000,000 At the 2014 AGM on 27-11-14
13,000,000 At the 2015 AGM on 30-11-15
17,000,000 At the 2015 AGM on 30-11-15
Subtractthe number of fully paid ordinary
securities cancelled during that 12 month
period
“A” 829,966,947
  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 5

Step 2: Calculate 15% of “A”

==> picture [406 x 606] intentionally omitted <==

----- Start of picture text -----

“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15 124,495,042
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of equity securities issued -
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2 -
• Under rule 7.1A -
• With security holder approval under -
rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable ) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
“C” -
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 124,495,042
Note: number must be same as shown in
Step 2
Subtract “C” -
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C” 124,495,042
[Note: this is the remaining placement
capacity under rule 7.1]
----- End of picture text -----

  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 6

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 829,966,947 Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 82,996,695

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

  • This applies to equity securities – not just ordinary securities

  • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • It may be useful to set out issues of securities on different dates as separate line items

  • “E” Nil

  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 7

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown
in Step 2
82,996,695
Subtract“E”
Note: number must be same as shown
in Step 3
-
Total[“A” x 0.10] – “E” 82,996,695
Note: this is the remaining placement capacity
under rule 7.1A
  • See chapter 19 for defined terms.

13/09/2013

Appendix 3B Page 8